US · Healthcare · Healthcare Plans
EPS came in at 6.38 against a street estimate of 4.94 — a beat of 29.1%.
Analysts rate UnitedHealth Group Incorporated a buy (20 buy, 5 hold, 2 sell out of 27) with an average price target of $475.23.
| Fund | Stake |
|---|---|
| BlackRock Inc | 8.18% |
| Vanguard Capital Management, LLC | 6.56% |
| State Street Corp | 5.05% |
| Capital World Investors | 3.33% |
| Vanguard Portfolio Management, LLC | 2.68% |
| Geode Capital Management, LLC | 2.54% |
| T. Rowe Price Associates, Inc. | 2.33% |
| Charles Schwab Investment Management Inc | 2.32% |
| Document | Date |
|---|---|
| Reg FD disclosure · Q3 2026 UNITEDHEALTH GROUP INCORPORATED - FORM 8-K SUMMARY OTHER NOTABLE POINTS • Document Type: Form 8-K current report filed September 8, 2026 with the Se | 2026-09-08 |
| Quarterly report · Q2 2026 UNITEDHEALTH GROUP - Q2 2026 10-Q SUMMARY HEADLINE NUMBERS • Net earnings attributable to common shareholders: $5.5 billion (Q2 2026) vs $3.4 billio | 2026-08-10 |
| Results announced · Q3 2026 UNITEDHEALTH GROUP Q2 2026 EARNINGS SUMMARY HEADLINE NUMBERS • Q2 2026 revenues: $112.0 billion (vs. $111.6 billion Q2 2025) • Earnings from operati | 2026-07-16 |
| Shareholder vote results · Q2 2026 UNITEDHEALTH GROUP INCORPORATED – FORM 8-K SUMMARY HEADLINE NUMBERS • Annual Meeting of Shareholders held June 1, 2026 • 768,066,717 shares of commo | 2026-06-05 |
| Reg FD disclosure · Q2 2026 UNITEDHEALTH GROUP INCORPORATED - DOCUMENT SUMMARY HEADLINE NUMBERS • This is a Form 8-K filing dated May 11, 2026 - a current report disclosing mat | 2026-05-11 |
| Quarterly report · Q1 2026 UNITEDHEALTH GROUP INCORPORATED – Q1 2026 10-Q SUMMARY HEADLINE NUMBERS • Total revenues: $111,721 million (Q1 2026) vs. $109,575 million (Q1 2025) | 2026-05-05 |
| Proxy statement · Q2 2026 UNITEDHEALTHGROUP INCORPORATED — 2026 PROXY SUMMARY WHAT SHAREHOLDERS ARE VOTING ON • Proposal 1: Election of Nine Directors — Vote FOR all nominees | 2026-04-21 |
| Annual report FY2025 UNITEDHEALTH GROUP - 10-K SUMMARY FOR RETAIL INVESTORS HEADLINE NUMBERS • Market capitalization as of June 30, 2025: $281.9 billion (based on $311.9 | 2026-03-02 |
Readable in the app.
| Action | Detail | Date |
|---|---|---|
| Dividend | $2.32 / share ex-date Sep 14, 2026 · pay Sep 22, 2026 | 2026-09-14 |
| Dividend | $2.32 / share ex-date Jun 15, 2026 · pay Jun 23, 2026 | 2026-06-15 |
| Dividend | $2.21 / share ex-date Mar 9, 2026 · pay Mar 17, 2026 | 2026-03-09 |
| Dividend | $2.21 / share ex-date Dec 8, 2025 · pay Dec 16, 2025 | 2025-12-08 |
| Dividend | $2.21 / share ex-date Sep 15, 2025 · pay Sep 23, 2025 | 2025-09-15 |
| Announcement | Date |
|---|---|
| Full year 2025 results reported; 2026 revenue and earnings outlook issued UnitedHealth Group reported strong 2025 revenues of $447.6 billion (12% growth), but earnings were heavily impacted by a $2.8 billion charge. Adjusted earnings of $16.35 per share exclude on | 2026-01-27 |
| Senior management to reaffirm adjusted 2025 EPS expectations at investor meetings UnitedHealth Group announced that senior management will meet with investors on January 12, 2026, to reaffirm its adjusted 2025 earnings per share (EPS) guidance previously provided on Octob | 2026-01-12 |
Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for UnitedHealth Group Incorporated — free to start.
Google PlayApp StoreData updated 2026-09-18.